新型糖尿病治疗药物Exendin-4的研究进展
出处
《中国药房》
CAS
CSCD
北大核心
2008年第23期1825-1827,共3页
China Pharmacy
基金
国家自然科学基金资助项目(30600413)
教育部科学技术研究重点项目(207064)
参考文献20
-
1Segal JB, Dy SM, Millman EA, et al. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy[J ]. Ulin Ther ,2007,29(8) : 1 784.
-
2Stephens JW, Bain SC. Safety and adverse effects associated with GLP- 1 analogues[J] .Expert Opin Drug; Saf, 2007, 6(4): 417.
-
3Combettes M, Karqar C. Newly approved and promising antidiabetic agents[J ].Therapie ,2007,62(4) :293.
-
4DeFronzo RA, Ratner RE, Han J, el al. Effects of exenatide (exendin-4) on glycemic control and weight over 30weeks in metformin - treated patients with type 2 diabetes [J ]. Diabetes Care, 2005,28(5) : 1 092.
-
5Buse JB, Henry RR, Han J, etal. Effects of exenatide (exendin -4) on glycemiccontrol over 30 weeks in sulfonylurea - treatedpatients with type 2 diabetes[J]. Diabete Care, 2004,27(11) : 2628.
-
6De Leon DD, Crulchlow MF, Ham JY, et al. Role of glucagon-like peptide- 1 in the pathogenesis and treatment of diabetes mellitus[J ]. Int J Biochem Cell Biol, 2006,38(5) : 845.
-
7Egan JM, Bulotta A, Hui H, et al. GLP - 1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells[J ] .Diabetes Metab Res Rev ,2003, 19(2) : 115.
-
8Fineman MS, Bicsak TA, Shen LZ, et al. Effect on glycemic control of synthetic exendin-4 (AC2993) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes [J ] . Physiol Be- hay Diabetes Care, 2003, 26(8): 2 370.
-
9Nielsen LL, Young AA, Parkes DG. Pharmacology of exenatide (synthetic exendin - 4) : a potential therapeutic for improved glycemic control of type 2 diabetes[J] . Regul Pept, 2004,117(2) : 77.
-
10Bonora E. Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin - based treatment on body weight[J] . Int J Clin Pract Suppl , 2007,8(154) : 19.
-
1李新禾.诺和灵N联合口服降血糖药治疗2型糖尿病疗效观察[J].中国基层医药,2004,11(2):233-233. 被引量：4
-
2尤传一.餐后2小时血糖一直高怎么办？[J].糖尿病之友,2005(6):59-59.
-
3闫秋艳.人胰岛素不良反应3例[J].中国误诊学杂志,2007,7(18):4440-4440. 被引量：4
-
4高增云,杨菊芬,陈国依.糖尿病患者血糖控制不理想的原因分析及对策[J].中国民康医学,2008,20(22):2655-2655.
-
5陈晓文,金亚,陈勇.甘精胰岛素联合阿卡波糖治疗2型糖尿病疗效[J].中国药师,2009,12(8):1107-1108. 被引量：5
-
6张连记.降低心血管并发症，使用胰岛素增敏剂要趁早[J].糖尿病之友,2009(4):36-37.
-
7李祖宙.甘精胰岛素联合格列美脲治疗老年2型糖尿病的疗效和安全性[J].海峡药学,2010,22(9):109-111. 被引量：13
-
8于桂娜,张晓倩,宋文焕.罗格列酮治疗2型糖尿病56例临床观察[J].山东医药,2002,42(19):36-37.
-
9袁秉煃.选用降压药，必须个体化[J].江苏卫生保健（今日保健）,2006(6):28-28.
-
10魏冰,刘屹嵩,姜海红,赵宏.甘精胰岛素联合格列美脲治疗2型糖尿病[J].实用糖尿病杂志,2010,6(1):21-22. 被引量：3
